U.S. Markets open in 56 hrs, 55 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,451.19 | -128.00 | -1.49% |
| NASDAQ | 1,649.51 | 4.39 | 0.27% |
| S&P 500 | 899.22 | -10.70 | -1.18% |
| Day Low 10:30 AM EDT | 14.50 | |
|---|---|---|
| Day High 12:46 PM EDT | 15.66 |
|
| Range | 1.16 | |
| Volume | 397,231 | |
| 30-Day Avg. Vol. | 239,000 |
|
| Difference | 66.21% | |
| Market Cap. | 543.93 M | |
| Change | -16.71 M | |
| Shares Out. | 36.33 M | |
| Percent Traded | 1.09% | |
| Revenue (LFY) | 7.12 M | |
| Earnings (TTM) | -40.35 M | |
| Next Earnings | 11/06/2008 |
|
| EPS (TTM) | -1.38 |
| 52-Wk Low 1/28/08 | 10.75 | |
|---|---|---|
| 52-Wk High 9/19/08 | 20.20 |
|
| Range | 9.45 | |
| Prev. Close 10/9/08 | 15.43 | |
| Today's Open | 15.06 | |
| Change | -2.40% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 0.7336 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -10.00 |
GTx knows hormones are just as important to men as they are to women. The company develops therapies targeting estrogens and androgens for prostate cancer and other diseases in the arena of men's health. ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.30 3/31/08 | -0.35 3/31/08 |
-0.05
Missed
|
| Last Quarter | -0.377 6/30/08 | -0.37 6/30/08 |
0.007
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 3.01 M | 7.13 M |
| Gross Profit | 2.48 M | 5.36 M |
| Operating Income | -13.94 M | -45.50 M |
| Net Income | -13.24 M | -40.36 M |
